Kala Pharmaceuticals (KALA) Misses Q2 EPS by 316c
Tweet
Share
E-mailGet Alerts KALA Hot Sheet
Join SI Premium – FREE
Kala Pharmaceuticals (NASDAQ: KALA) reported Q2 EPS of ($3.16).
For earnings history and earnings-related data on Kala Pharmaceuticals (KALA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs (GS) Reiterated at Market Perform by Citizens on Constructive Backdrop
- Barclays Downgrades Brown Forman (BF-B) to Equalweight
- NRC Health (NRC) Reiterated at Market Outperform by Citizens Ahead of Annual Forum
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
